Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
21.92
-0.56 (-2.49%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Bicara Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 1,435 | 922 | 948 | - | - |
| Market Cap Growth | 159.31% | -2.74% | - | - | - |
| Enterprise Value | 1,022 | 634 | 428 | - | - |
| Last Close Price | 21.92 | 16.83 | 17.42 | - | - |
| PB Ratio | 2.97 | 2.30 | 1.93 | - | - |
| P/TBV Ratio | 3.57 | 2.30 | 1.93 | - | - |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Net Debt / Equity Ratio | -1.03 | -1.03 | -0.99 | -1.05 | 0.24 |
| Net Debt / EBITDA Ratio | 2.66 | 2.66 | 5.94 | 5.76 | 0.11 |
| Net Debt / FCF Ratio | 3.86 | 3.86 | 6.54 | 4.97 | 0.13 |
| Quick Ratio | 14.33 | 14.33 | 27.22 | 15.28 | 0.17 |
| Current Ratio | 14.58 | 14.58 | 27.93 | 15.32 | 0.21 |
| Return on Equity (ROE) | -30.88% | -30.88% | -19.14% | -51.67% | - |
| Return on Assets (ROA) | -20.67% | -20.67% | -13.84% | -20.72% | - |
| Return on Capital Employed (ROCE) | -38.70% | -38.70% | -16.70% | -18.20% | 219.00% |
| Earnings Yield | -9.61% | -14.96% | -7.17% | - | - |
| FCF Yield | -7.46% | -11.62% | -7.89% | - | - |
| Buyback Yield / Dilution | -225.35% | -225.35% | -2796.96% | -35.20% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.